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SUMMARY
Cas9 nucleases can be programmed with single
guide RNAs (sgRNAs) to mediate gene editing. High
CRISPR/Cas9-mediated gene knockout efficiencies
are essential for genetic screens and critically
depend on the properties of the sgRNAs used. The
specificity of an sgRNA is defined by its targeting
sequence. Here, we discovered that two short
sequence motifs at the 30 end of the targeting
sequence are almost exclusively present in ineffi-
cient sgRNAs of published sgRNA-activity datasets.
By specific knock-in of sgRNA target sequences with
or without these motifs and quantitative measure-
ment of knockout efficiency, we show that the pres-
ence of these motifs in sgRNAs per se results in a
10-fold reduction of gene knockout frequencies.
Mechanistically, the cause of the low efficiency dif-
fers between the two motifs. These sequence motifs
are relevant for future sgRNA design approaches and
studies of Cas9-DNA interactions.
INTRODUCTION
The CRISPR/Cas9 technology is a powerful tool for genome ed-
iting (Cong et al., 2013; Jinek et al., 2012). Cas9 nucleases can
be programmed with single guide RNAs (sgRNAs) to generate
gene knockouts by inducing frameshift mutations in protein-
coding genes. High CRISPR/Cas9-mediated knockout effi-
ciencies are essential for genetic screens because of their
impact on the signal-to-noise ratio, and they critically depend
on the properties of the sgRNAs used. sgRNAs consist of a tar-
geting sequence, defining their specificity, followed by the scaf-
fold RNA at the 30 end. Previous studies based on large-scale
measurements of sgRNA activity have identified targeting
sequence features that affect the on-target efficiency. Targeting
sequences with a very high (R80%) or low (%35%) guanine-
cytosine (GC) content overall were less effective. Furthermore,
Cas9 has been shown to preferentially bind sgRNAs with purines
in the four protospacer adjacent motif (PAM)-proximal bases of
the targeting sequence, whereas pyrimidines and, especially,
thymines (Ts) were disfavored (Wang et al., 2014). Along these
lines, guanine (G) and cytosine (C) were found to be preferred
and unfavorable, respectively, as the last base before the PAM
(Doench et al., 2014). Overall, a bias against thymines at the
30 end of the targeting sequence has been observed (Doench
et al., 2014; Moreno-Mateos et al., 2015; Xu et al., 2015). While
these features based on enrichments with respect to efficiency
helped to improve sgRNA design criteria, they, by definition,
do not allow researchrs to predict with certainty whether an
sgRNA is inefficient.
Using sgRNAs designed with the sgRNA design tool
CrispRGold and Cas9-transgenic mice, we achieved high homo-
zygous knockout frequencies in primary B cells and other he-
matopoietic cells (Chu et al., 2016). Unexpectedly, one sgRNA
reproducibly led to very low knockout frequencies. This sgRNA
had a short T-rich sequence at its 30 end that was not present
in functional sgRNAs. Following up on this observation, we
show here that this sequence belongs to one of two sequence
motifs that are almost exclusively present in low-efficiency
sgRNAs in published sgRNA-activity datasets. Using CRISPR-
mediated specific knock-in of sgRNA target sequences followed
by gene targeting, we demonstrate that the presence of these
motifs results in drastically decreased knockout frequencies
and that the mechanisms leading to these low efficiencies differ
between the two motifs.
RESULTS
In the course of developing efficient CRISPR/Cas9-mediated ge-
netic screens in primary cells, we previously transduced wild-
type and Cas9-transgenic activated B cells with retroviruses
encoding sgRNAs targeting 12 surface markers, leading to an
average knockout frequency of 80% (Chu et al., 2016). One
sgRNA against CD22 (CD22-2) led to an extremely low knockout
frequency of 10%, despite matching the stringent design
criteria that otherwise defined efficient sgRNAs. This effect could
not be explained by the positional nucleotide composition of the
targeting sequence, as we had observed high knockout fre-
quencies with all nucleotide types at every position of the target-
ing sequence (Figure S1A). Moreover, a second sgRNA targeting
CD22 that was only 9 bps upstream of CD22-2 worked with high
efficiency, indicating that the low knockout efficiency of CD22-2
was not a peculiarity of the genomic locus. We thus looked at
more complex features of the CD22-2 sgRNA and identified a
T-rich sequence at the 30 end of the targeting sequence as
unique in our sgRNA pool. By testing additional sgRNAs with
such T-rich sequences at this position (targeting CD22 and
1098 Cell Reports 26, 1098–1103, January 29, 2019 ª 2019 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
AB C D
E
F
G
H
Lamin B1
Self-cleavage
Figure 1. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing
(A) Flow cytometry plots showing the knockout frequencies (lower right gate) of CD22 (top) and B220 (bottom) in primary B cells isolated from Cas9-transgenic
(GFP+) animals 4 days post-transduction with retroviruses encoding the indicated sgRNAs. The sequences in the four PAM-proximal bases of the targeting
sequence (hereafter called efficiency-modulating sequence [EMS]) are shown in orange (T-rich) or blue (control); the PAM is shown in gray. Data are repre-
sentative for two independent experiments.
(B) Number of sgRNAs with the indicated sequences in the EMS in the inefficient (last 25%) or efficient (top 25%) sgRNAs reported by Doench et al. (2014).
(legend continued on next page)
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B220), we discovered that all of these sgRNAs led to very low
knockout frequencies (Figure 1A). These data suggested that
specific T-rich sequences within the last four bases of the target-
ing sequence are sufficient to severely impede knockout effi-
ciency. To confirm this observation with an independent dataset,
we re-analyzed the surface marker knockout-based sgRNA-ac-
tivity dataset reported by Doench et al. (2014). Consistent with
our results, T-rich sequences were significantly overrepresented
in the least active sgRNAs (percentage rank %25%) compared
to the most active ones (percentage rank R75%) (Figure 1B).
Based on these observations, we could refine the T-rich effi-
ciency-modulating sequence at the 30 end of the targeting
sequence to consist of a TT-dinucleotide and at least one pyrim-
idine (TT + Y) or of four pyrimidines with at least two Ts (2T + 2Y),
termed TT-motif hereafter. In addition, this motif analysis led to
the discovery of four additional efficiency-modulating se-
quences at the same position that share a GCC core (DGCC
and GCCT) (termed GCC-motif hereafter). In the dataset of
Doench et al. (2014), these sequences were almost exclusively
present in the least active sgRNAs (Figure 1B). sgRNAs contain-
ing the TT- or GCC-motif had a significantly lower overall
knockout activity rank than the entire set of sgRNAs (Figure 1C).
To prove that these motifs are solely responsible for the low
knockout efficiency, we removed all of the other variables (e.g.,
locus context) by targeting sgRNA target sequences into the
Lamin B1 (Lmnb1) locus of a Cas9-expressing mouse tumor
cell line and expressing the respective sgRNAs using retrovi-
ruses (Sander et al., 2012). To do so, we designed a unique
sgRNA target sequence that is not present in the mouse genome
and targeted 22 variants of this sequence (each variant was fol-
lowed by a self-cleavage peptide and GFP) in front of the 30 UTR
of the Lmnb1 gene using CRISPR/Cas9 (Figure 1D). This system
was functional and led to reproducible knockout frequencies
(Figures 1E and S1B). Consistent with previous reports, purines
in front of the PAM led to slightly increased knockout fre-
quencies. In contrast, all of the sgRNAs with the GCC- and
TT-motifs led to drastically (10-fold) decreased knockout fre-
quencies (Figures 1F and S1C). We verified that the target se-
quences in GFP+ cells with a TT-motif (TTCA) were unmodified,
showing that the respective sgRNA did not lead to gene editing
(Figure S1D). Moreover, these efficiency-modulating motifs ac-
counted for all of the low-efficiency sgRNAs in our previously
published surface marker knockout experiment (Figure 1G)
(Chu et al., 2016). These data show that the TT- and GCC-motif
in the four PAM-proximal bases of the targeting sequence per se
can render sgRNAs inefficient in CRISPR-mediated gene editing
(Figure 1H). These sgRNA design restrictions were thus
implemented in the CrispRGold sgRNA design tool (https://
crisprgold.mdc-berlin.de).
Addressing the underlying mechanism of the low knockout
efficiencies, we performed follow-up experiments using two
control sgRNAs (Ctrl1/Ctrl2) and two sgRNAs per TT- and
GCC-motif (TT1/TT2 and GC1/GC2, respectively) (Figure 2A).
We first folded all of the sgRNAs in silico and did not find a struc-
tural feature that was peculiar to the motif sgRNAs (Figure S2A)
(Lorenz et al., 2011). To find out whether the motifs directly
impede Cas9-mediated DNA cleavage, we performed in vitro
cleavage assays using ribonucleoprotein particles (RNPs) con-
sisting of Cas9 and synthetic sgRNAs. All of the sgRNAs effi-
ciently cleaved the target DNA in vitro, indicating that the motifs
do not directly block Cas9-mediated DNA cleavage (Figures 2B
and S2B). In addition, transfection of the synthetic sgRNAs into
the respective cell lines rescued the knockout efficiency in the
case of the TT-motif, but not the GCC-motif (Figure 2C). In these
experiments, we also observed that the TT-motif sgRNAs were
less efficient than the control sgRNAs at low doses (Figure S2C).
These results suggested that the TT-motif sgRNAs were ineffi-
cient due to low doses when expressed from viral vectors.
Indeed, the TT1/TT2 sgRNAs were transcribed less efficiently
in vitro, leading to levels that were similar to the levels obtained
with an sgRNA having an RNA polymerase III termination signal
(five Ts) at the 30 end of the targeting sequence (Figure 2D). Thus,
T-rich sequences at the 30 end of the targeting sequence led to
reduced transcription, as it had been suggested before, likely
due to the proximal tetra-T sequence at the 50 end of the scaffold
RNA (Doench et al., 2014). Inspired by previous reports on scaf-
fold optimization, we designed variants of the scaffold RNA by
mutating position five (T5A) or three and four (TT3AA) and the
corresponding complementary nucleotides in the stem structure
to interrupt the T-stretch (Figure 2E) (Chen et al., 2013; Dang
et al., 2015; Hsu et al., 2013). The T5A scaffold fully restored
the knockout activity of the TT-motif sgRNAs (Figure 2F). In
contrast, the TT3AA scaffold only partially restored the knockout
activity of these sgRNAs. Both mutated scaffold variants did not
restore the knockout activity of GC1/GC2, further indicating that
the low efficiency of these sgRNAs has other causes (Figure 2G).
To test whether the GCC-motif sgRNAs are efficiently loaded
into Cas9 or potentially have a higher off-rate, we performed
(C) Boxplots of the sgRNA activities reported by Doench et al. (2014), considering all of the sgRNAs (black) or the sgRNAs with the indicated motifs in the EMS
(orange). The top, middle, and bottom lines of the boxplot represent the 25th, 50th, and 75th percentiles, respectively; the whiskers represent the max and min
values. Subgroups were compared to the control set using ordinary one-way ANOVA (****p < 0.0001).
(D) Scheme of validation experiment. sgRNA target sequences followed by T2A and GFP were targeted in-frame into the Lamin B1 locus of a mouse B cell tumor
cell line usingCRISPR/Cas9. GFP+ cells were subcloned, transduced using retroviruses encoding the respective sgRNAs, and cultured for 8 days before analysis.
(E) Example of GFP knockout measurement (GFP KO gate) by flow cytometry 8 days post-transduction with the indicated sgRNA, as in the experimental system
shown in (D).
(F) Heatmap of the GFP knockout frequencies in the cell lines with the indicated sequences in the EMS 8 days post-transduction with the respective sgRNAs.
Sequences matching the TT- and GCC-motifs are shown in orange.
(G) Knockout frequencies in Cas9-transgenic primary B cells 4 days post-transduction with sgRNAs, normalized to the higher knockout frequency of the two
sgRNAs used. The sgRNAs matching the TT- or GCC-motifs are encircled, and the respective sequences indicated. Data are based on two independent ex-
periments and adapted from Chu et al. (2016).
(H) Schematic diagram of the targeting sequence of the sgRNA (blue and orange) bound to the DNA (black). The four PAM-proximal nucleotides of the targeting
sequence (orange) were called EMS due to their potential for modulating knockout frequencies. The predicted CRISPR/Cas9-mediated DNA cut is indicated.
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Figure 2. Mechanism of Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing
(A) Targeting sequences of the sgRNAs used to study mechanism of motifs. The four PAM-proximal bases are highlighted in blue and orange.
(B) In vitro cleavage assay using ribonucleoprotein particles (RNPs) with the indicated sgRNAs and amplified target sequences.
(C) Knockout frequencies in vivo 2 days post-electroporation with the indicated synthetic sgRNAs.
(D) sgRNAs produced by in vitro transcription of the indicated sgRNAs and a negative control sgRNA having five Ts at the 30 end of the targeting sequence (5-T).
(legend continued on next page)
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Cas9-loading and in vitro cleavage competition assays. All
sgRNAs were efficiently loaded into Cas9 in vitro (Figure S2D).
In addition, in the sgRNA competition assay, increasing doses
of GC1 and GC2 prevented the Ctrl1 sgRNA from cleaving its
target in a dose-dependent manner, similar to TT2 (which served
as control here), which indirectly indicated that GC1 and GC2
were efficiently loaded into Cas9 (Figure 2H). Of note, even
when the GCC-motif sgRNAs were preloaded into Cas9
in vitro, they showed poor knockout activity in vivo when deliv-
ered as RNPs to the cell lines by electroporation (Figure S2E).
These data suggested that the GCC-motif sgRNAs inefficiently
recruit Cas9 to the target site in vivo. Increased doses of syn-
thetic sgRNAs to the respective cell lines did not lead to
increased knockout frequencies for the GCC-motif sgRNAs, as
was the case for the control and TT-motif sgRNAs (Figure 2I).
This was consistent with a decreased binding of the sgRNA/
Cas9 complex to the respective target sites in the case of the
GCC-motif, as measured by the immunoprecipitation of Cas9
and qPCR (Figure 2J). These data show that the TT-motif
sgRNAs are ineffective because of the low expression when vir-
ally expressed, which can be overcome by alternative expres-
sionmethods ormutated scaffold RNAs, whereas theGCC-motif
sgRNAs show a general deficiency in accessing their target sites
in vivo. As a consequence, the TT-motif sgRNAs should be
avoided in polymerase III (Pol III)-based gene editing experi-
ments requiring high sgRNA expression levels, especially in the
context of genetic screens, where they can lead to false-nega-
tives. In contrast, the GCC-motif sgRNAs appear to be inefficient
irrespective of the delivery method and should thus be generally
avoided.
DISCUSSION
Given the strong impact of the two sequence motifs reported
here on gene editing efficiency, these motifs are relevant for
future sgRNA design approaches and studies of the Cas9-
mediated gene editing mechanism. Of note, both motifs are
located in the sgRNA ‘‘seed’’ region (the PAM-proximal 10–12
bases of the targeting sequence) that is important for pairing
with the target DNA (Jinek et al., 2012). The bias against
T-rich sequences at the end of the targeting sequence has pre-
viously been observed and explained as a possible conse-
quence of RNA polymerase III termination at such T-rich
sequence stretches, which would include the four Ts following
the initial G of the scaffold RNA (Doench et al., 2014). An alter-
native explanation of the TT-motif is the reported negative
impact of Ts among the last four bases at the 30 end of the tar-
geting sequence on sgRNA loading into Cas9 (Wang et al.,
2014). We show here that the low efficiency of the TT-motif
sgRNAs is indeed related to their reduced expression level,
amplifying the decreased efficiency at low dosage potentially
caused by a reduced loading into Cas9. The strong reduction
in transcription caused by the TT-motif in vitrowas unexpected,
as efficient halting and release of RNA by RNA polymerase III is
thought to require at least five Ts in a row (Arimbasseri and Mar-
aia, 2015). However, the fact that bacteria did not change this
scaffold feature through evolution is not surprising, given the
differences in RNA polymerases between bacteria and eukary-
otes and the fact that the targeting sequence and the scaffold
RNA are transcribed from different loci in bacteria (Jinek
et al., 2012). Halting and release of RNA polymerase III is
context dependent. In fact, even differences in promoters
have been shown to affect RNA polymerase III termination effi-
ciencies on T-stretches (Gao et al., 2018). We show that a
mutated version of the scaffold (T5A) may restore the knockout
activity of the TT-motif sgRNAs. This scaffold has previously
been shown to improve knockout efficiency in a motif-unrelated
context (Chen et al., 2013; Dang et al., 2015; Hsu et al., 2013).
Thus, the T5A scaffold RNA is an interesting candidate to
replace the standard scaffold RNA in virus-based CRISPR
screens.
The case of the low efficiency of the GCC-motif sgRNAs is
more complex. The potential underlying mechanisms range
from inefficient loading over non-specific binding to off-targets
to co-factor-dependent mechanistic problems. Our results sug-
gest that these sgRNAs are either inactivated in vivo (e.g., by
RNA-binding proteins) or incompetent to correctly scan and
bind the target site (e.g., due to enhanced unspecific binding
to off-targets or interference of the GC-rich sequence with
proper PAM recognition). High-throughput experiments will be
needed to investigate these possibilities.
While thepresent study showsaconsistent negative impact of
the motifs on knockout efficiency in human andmouse cell lines
as well as primary mouse B cells, cell type-specific variations
may exist. Furthermore, while our study did not include experi-
ments involving dCas9, the in vitro data suggest that the motifs
may also reduce target gene regulation inCRISPRi (interference)
and CRISPRa (activation) experiments, as they do not interfere
at the level of DNA cutting (Gilbert et al., 2013; Qi et al., 2013).
Although significant progress has beenmade in sgRNA design
during the last few years, our data uncover definable sgRNA fea-
tures that on their own block knockout efficiency (Doench et al.,
2016). Additional such features may exist that per se modulate
knockout efficiency. A further de-convolution of overall sgRNA
efficiencymay thus lead to an improved understanding of sgRNA
activity.
(E) Scheme of the 30 end of the targeting sequence and the 50 end of the scaffold RNA. The four Ts in the scaffold were mutated to the indicated variants (T5A and
TT3AA).
(F) Knockout frequencies 8 days post-transduction, with sgRNAs consisting of the indicated targeting sequences and variants of scaffold RNAs.
(G) Heatmap of the knockout frequencies obtained with the mutated scaffolds as in (F) in three clones (Cl) per condition.
(H) In vitro cleavage assay using Ctrl1 and the Ctrl1 target site in the presence of increasing levels (03, 0.53, 13, 23, 43, 83, and 83) of the indicated competing
sgRNAs.
(I) Heatmap of the knockout frequencies 8 days post-electroporation, with increasing doses of the indicated synthetic sgRNAs.
(J) Quantification of target sites bound to Cas9. Cas9 was immunoprecipitated 16 h post-transfection with sgRNA-encoding plasmids. Data are representative for
two independent experiments.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
APC-B220 (Clone RA3-6B2) BioLegend Cat#103212; RRID:AB_312997
BV786-CD19 (Clone 6D5) BioLegend Cat#115543; RRID:AB_11218994
PE-CD22 (Clone OX-97) BioLegend Cat#126112; RRID:AB_2561632
anti-flag M2 antibody Sigma Cat#F1804; RRID:AB_262044
Bacterial and Virus Strains
DH5a Thermofisher Cat#18265017
Chemicals, Peptides, and Recombinant Proteins
aCD40 BioLegend Cat#102802
IL-4 Peprotech Cat#214-14
IL-21 Peprotech Cat#210-21
Cas9 Homemade N/A
Puromycin Sigma Cat#P8833
Critical Commercial Assays
CD43 (Ly-48) MicroBeads, mouse Miltenyi Biotec Cat#130-049-801
FugeneHD transfection reagents Promega Cat#E2312
MEGAscript T7 transcription Kit Thermo Fisher Scientific Cat#AM1354
Alt-R CRISPR-Cas9 sgRNA IDT N/A
Alt-R CRISPR-Cas9 tracrRNA IDT N/A
SYBR Green PCR Master mix Applied Biosystems Cat#4309155
Zero Blunt TOPO PCR Cloning Kit Invitrogen Cat#450245
Experimental Models: Cell Lines
Plat-E packaging cells Cell Biolabs RV-101
40LB feeder cells Nojima et al., 2011 N/A
Murine Burkitt lymphoma cell line Sander et al., 2012 N/A
Experimental Models: Organisms/Strains
C57BL/6 Taconic B6NTac
R26-Cas9iGFP/+ Chu et al., 2016 N/A
Oligonucleotides
T5A-gRNA scaffold sequence: GTTTAAGAGCTAGAAATAGCAAGTTTAAATAAG
GCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGC
This paper N/A
TT3AA-gRNA scaffold sequence: GTAATAGAGCTAGAAATAGCAAGTTATTATA
AGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGC
This paper N/A
ChiP-qPCR forward primer: AATCTTAACTGTTTACAGGCCTAGGTCAGCT This paper N/A
ChiP-qPCR reverse primer: CTCCACGTCACCGCATGTT This paper N/A
Knock-in genotyping forward primer: AATCTTAACTGTTTACAGGCCTAGGTC
AGCT
This paper N/A
Knock-in genotyping reverse primer: TTACTTGTACAGCTCGTCCATGCC This paper N/A
In vitro T7 transcription template forward primer: TTAATACGACTCACTATAGG
(+sgRNA)
This paper N/A
In vitro T7 transcription template reverse primer: AAAAGCACCGACTCGGTGCC This paper N/A
Recombinant DNA
MSCV_hU6_CcdB_PGK_Puro_T2A_BFP Chu et al., 2016 N/A
pTV_Lmnb1_BsmBI_T2A_GFP This paper N/A
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Further information and requests for resources and reagents should be directed to and will be fulfilled by Klaus Rajewsky (Klaus.
Rajewsky@mdc-berlin.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
C57BL/6mice were purchased from Taconic. R26-Cas9iGFPmice were generated by CRISPR/Cas9 and zygote injection (Chu et al.,
2016). R26-Cas9iGFP/+ were generated by crossing R26-Cas9iGFP to C57BL/6 mice. All mice were kept in specific pathogen-free
facilities. All mice usedweremale and24 weeks old. All animal care and procedures were approved by the Institutional Animal Care
and the LaGeSo Berlin.
Cell lines
The Burkitt lymphoma cell line (male) was generated before (Sander et al., 2012). Stable Cas9 expression was achieved by retroviral
transduction and subcloning to obtain homogeneous Cas9 expression. Cells were cultured in B cell medium (DMEM high glucose,
10% FCS (GIBCO), L-Glutamine (2 mM, GIBCO), HEPES (2 mM, GIBCO), Non-essential amino acids (1x, GIBCO), sodium pyruvate
(2 mM, GIBCO), Penicillin/Streptomycin (100 U/ml, GIBCO), b-mercaptoethanol (52 mM, Sigma)).
Primary cells
Primary B cells were isolated from spleens of adult C57BL/6 and R26-Cas9iGFP/+ mice by CD43-depletion (Miltenyi) according to
the manufacturer’s protocol. Cells were cultured in B cell medium.
METHOD DETAILS
Knockout in primary B cells
Knockout experiments in primary B cells were performed as described before (Chu et al., 2016). Briefly, primary B cells fromC57BL/6
and R26-Cas9iGFP/+ mice were mixed at a 1:4 ratio. These cells were then activated with anti-CD40 (2 mg/ml, BioLegend) and IL-4
(20 ng/ml, Peprotech) for two days, spin-transduced with retroviruses encoding the sgRNAs and cultured for four days on 40LB
feeder cells with IL-21 (20 ng/ml, Peprotech) until analysis.
Motif analysis
sgRNA sequences were extracted fromDoench et al. (Doench et al., 2014) and Chu et al. (Chu et al., 2016) and the sequence variants
in the last four bases of the targeting sequence were counted.
Validation of low-efficiency motifs in B cell tumor cell line
The constructs containing the sgRNA target sites, T2A and GFP were targeted in-frame into the endogenous Lmnb1 locus (in front of
the 30 UTR) of a mouse Burkitt lymphoma cell line (Sander et al., 2012) by homologous directed repair and CRISPR/Cas9 (using
GTCTTGACAAGTTCACATAA as sgRNA target in Lmnb1 and 1.4kb up-stream and 2kb downstream targeting arms). The GFP pos-
itive cells were sub-cloned by FACS single cell sorting (BD AriaII/III). Correct targeting of each clone was assessed by PCR and
Sanger sequencing. sgRNA targeting sequences were cloned into the BbsI sites of the MSCV_U6_CcdB_PGK_Puro_T2A_BFP vec-
tor as described before (Chu et al., 2016). Retroviruses were produced in Plat-E cells. Cell line sub-clones were transduced using
spin-transduction in 96-well plates, selected with 1.25 mg/mL puromycin (Sigma) and acquired using BD Fortessa with 96-well
HTS unit eight days later.
Sequence analysis
GFP+ and GFP- cells were sorted from heterozygous clones (in parallel to the analysis by FACS) using BD AriaII/III and directly lysed.
PCR amplicons were sub-cloned using TOPO cloning and sequenced using Sanger sequencing.
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Prism 7.0a GraphPad https://www.graphpad.com/
FlowJo v10 LLC https://www.flowjo.com/
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Sequence folding
The secondary structures of the sgRNAs were predicted with the RNAfold tool (Vienna Package, Lorenz et al.). The secondary struc-
tures shown in the figures were adapted from these predictions.
In vitro cleavage assay
The substrate DNA (target site) was amplified by PCR and incubated for 1h at 37C with the synthetic sgRNA (IDT) and Cas9 (home-
made). The reaction was stopped using 1 ml of stop solution (30%glycerol, 1.2%SDS, 250mMEDTA) at 37C for 15min. The cleaved
products were separated by gel electrophoresis.
In vivo knockout using synthetic sgRNAs
The indicated amounts of sgRNAs (1x corresponding to 50 pmol) were electroporated into the cell lines using a 4D-Nucleofector
(Lonza). To generate RNPs, 600 ng Cas9 proteins (homemade) and 100 pmol of synthetic sgRNAs were incubated at room temper-
ature for 15 min prior to electroporation.
In vitro transcription
In vitro transcription was performed using theMEGAscript T7 Transcription Kit (Applied Biosystems) according to themanufacturer’s
protocol.
ChIP and qPCR on target site
The plasmids encoding the sgRNAs were transfected into the cell lines. 14h post transfection, the cells were fixed and used for IP
using an anti-flag M2 antibody (Sigma). The target site was amplified using the SYBR Green PCR Master mix (Applied Biosystems)
according to the manufacturer’s protocol. The target site Cts were normalized to genomic Actb measurements.
QUANTIFICATION AND STATISTICAL ANALYSIS
P values were computed with Prism (version 7.0a) using ANOVA (with Bonferroni correction for multiple testing and assuming
Gaussian distributions). Four asterisks indicate a p value below 0.0001. P values were confirmed using Mann-Whitney and
Kolmogorov-Smirnov tests. In the case of primary cells, one mouse per genotype was used per biological replicate. Knockout fre-
quencies were quantified using flow cytometry and FlowJo (version 10, LLC) by gating on GFP- cells. The number of biological rep-
licates for each type of experiment is outlined in the figure legends or shown as data points in figures.
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